Inspire Medical Systems (INSP) said Monday that it signed a $75 million accelerated share repurchase agreement with Goldman Sachs (GS).
The company said the accelerated share repurchase transaction is scheduled to terminate in Q1 2025 and is under its previously announced $150 million share buyback program, which is set to expire in August 2026.